Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
Amount Of Epogen And Procrit Given To Patient Tripled Since Early ’90s
Higher Levels Of Popular Anemia Drugs May Increase Risk Of Heart Problems And Death The most recent discussion about safety issues surrounding the anemia drug epoetin — sold by Amgen as Epogen, sold by…
-
Ortho Evra: More Women Sue J&J Over Birth Control Patch
Lawsuits Allege Serious Blood Clots Conditions Such As Pulmonary Embolism, With One Young Woman Dying From Using Ortho Evra In early November 2006 two new California Ortho Evra lawsuits were filed in San Francisco…
-
FDA Approves New, Stronger Warnings For ADHD Drugs
Sudden Deaths, Strokes, And Heart Attacks In Adults At Usual Doses Several drugs to treat attention deficit hyperactivity disorder (ADHD) — including GlaxoSmithKline (GSK) Plc’s Dexedrine, Novartis AG’s Ritalin, Johnson & Johnson’s Concerta, and…
-
Cox-2 Drugs Increase Risk Of Second Heart Attack Or Death When Used After First Heart Attack
Will June 2006 Circulation Article Affect Lawsuits Involving Bextra, Celebrex, And Vioxx? In mid-June 2006 the medical journal Circulation published online an early-release version of a study which reveals that Bextra, Celebrex, and Vioxx…
-
Birth Control Patch Lawsuits Being Settled Early By Johnson & Johnson
Ortho Evra Contraceptive Patch Causes Blood Clots Resulting In Strokes, Heart Attacks, Pulmonary Embolism, And Deep Vein Thrombosis According to a May 16, 2006 article in the New Jersey Law Journal, Johnson & Johnson…
-
Already Poor Visibility In The Vioxx Litigation Seemingly Gets Worse
What Do The Latest Vioxx Study Results Mean, And What Will Merck Do? The assertions, claims, and interpretations about what the new data from the so-called "Approve" study means regarding any increased risk of…
-
Concern Expressed About Heart Risks From Adderall, Ritalin, Other ADHD Drugs
Early Release of Dr. Nissen’s NEJM Article: "ADHD Drugs and Cardiovascular Risks" Cardiologist Steven E. Nissen believes that Shire Plc’s Adderall, Novartis AG’s Ritalin, and other drugs used to treat attention deficit-hyperactivity disorder (ADHD)…
-
Pfizer’s Painkiller Celebrex May Increase Heart Attack Risk, Like Vioxx and Bextra
New Zealand Study Indicates This Increased Risk Is "Class Effect" of COX-2 Inhibitors Pfizer Inc.’s painkiller Celebrex doubles a patient’s risk of having a heart attack, according to a report about a New Zealand…
-
FDA Reviewing Safety Of Bayer’s Heart Surgery Drug Trasylol
Studies Link Trasylol To Kidney Problems, Heart Attacks, and Strokes In mid-February 2006 the FDA issued a Public Health Advisory informing doctors and patients that the agency was evaluating the safety of Bayer AG’s…
-
Adderall and Ritalin: With Heart Risks Uncertain, What Should Patients Do?
Some Medical Advice About ADHD/ADD Drugs From Cardiologists And Psychiatrists In mid-February 2006 came the news that an advisory panel of drug-safety experts recommended a "black-box" warning for Adderall, Ritalin, and the other ADHD/ADD…